UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

BMC cancer, 2021-09, Vol.21 (1), p.1-1018, Article 1018

2021

Volltextzugriff (PDF)

A survey of treatment approaches of malignant ascites in Germany and Austria

Supportive care in cancer, 2015-07, Vol.23 (7), p.2073-2078

2015

Volltextzugriff (PDF)

Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?

Annals of oncology, 2005-07, Vol.16 (7), p.1210-1211

2005

Volltextzugriff (PDF)

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients

Annals of oncology, 2007-03, Vol.18 (3), p.479-484

2007

Volltextzugriff (PDF)

Use of Paclitaxel for Advanced Ovarian Cancer in Clinical Practice: Analysis of 541 Patients. Results from a German Multi-centre Observational Study

Anticancer research, 2010-10, Vol.30 (10), p.4245-4250

2010

Volltextzugriff (PDF)

Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial

Annals of oncology, 2006-06, Vol.17 (6), p.957-961

2006

Volltextzugriff (PDF)

Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries

Annals of oncology, 2018-04, Vol.29 (4), p.910-916

2018

Volltextzugriff (PDF)

MONITOR VII: Treatment strategies of low grade ovarian carcinomas – A German survey of the Charité – Berlin and Kliniken Essen Mitte with support of the study groups NOGGO and AGO

Annals of oncology, 2018-10, Vol.29, p.viii355-viii355

2018

Volltextzugriff (PDF)

Expectations and perspectives of ovarian cancer patients about cancer management in Romania. The international NOGGO‐ENGOT trial: EXPRESSION III

European journal of cancer care, 2017-11, Vol.26 (6), p.e12566-n/a

2017

Volltextzugriff (PDF)

Nachsorge des Ovarialkarzinoms

Der Onkologe, 2009-04, Vol.15 (4), p.433-440

2009

Volltextzugriff (PDF)

The Pathogenetic Mechanism of Anthracycline-induced Palmar-plantar Erythrodysesthesia

Anticancer research, 2009-06, Vol.29 (6), p.2307-2313

2009

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: results of a German multicenter observational study

Cancer chemotherapy and pharmacology, 2009-07, Vol.64 (3), p.585-591

2009

Volltextzugriff (PDF)

Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: Results of a multicenter phase II study of the northeastern German society of gynecological oncology

Gynecologic oncology, 2010-03, Vol.116 (3), p.317-322

2010

Volltextzugriff (PDF)

8029 The expression of CASA in ascites correlates with the overall survival and clinical outcome in patients with ovarian cancer

European journal of cancer supplements, 2009, Vol.7 (2), p.458-458

2009

Volltextzugriff (PDF)

000140 CAN A BIWEEKLY SCHEDULE REDUCE THE TOXICITY OF CAELYX? A PHASE-II STUDY OF HEAVILY PRETREATED PATIENTS WITH RECURRENT OVARIAN CANCER

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.92-92

2005

Volltextzugriff (PDF)

Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

Annals of oncology, 2010-11, Vol.21 (11), p.2201-2205

2010

Volltextzugriff (PDF)

8002 What is the best schedule of Topotecan? – weekly versus routine 5-day schedule in patients with platinum-resistant ovarian cancer – a randomized, multicenter trial of the North-Eastern German Society of Gynaecological Oncology (TOWER)

European journal of cancer supplements, 2009, Vol.7 (2), p.450-451

2009

Volltextzugriff (PDF)

8067 Platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

European journal of cancer supplements, 2009, Vol.7 (2), p.469-469

2009

Volltextzugriff (PDF)

8057 How relevant is the CA-125 monitoring for patients with ovarian cancer in the follow-up? – Results from a multicenter survey in 1060 patients with ovarian cancer

European journal of cancer supplements, 2009, Vol.7 (2), p.466-466

2009

Volltextzugriff (PDF)

00030 INFORMATION NEEDS AND PREFERENCES OF WOMEN WITH ADJUVANT AND METASTATIC BREAST CANCER (BC): RESULTS OF A SURVEY IN GERMANY

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.59-59

2005

Volltextzugriff (PDF)

Aktuelle Aspekte der Therapie des platinresistenten Ovarialkarzinoms

Geburtshilfe und Frauenheilkunde, 2007-08, Vol.68 (8), p.823-830

2007

Volltextzugriff (PDF)

995PMONITOR VII: Treatment strategies of low grade ovarian carcinomas - A German survey of the Charité - Berlin and Kliniken Essen Mitte with support of the study groups NOGGO and AGO

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

MONITOR VII – Behandlungsstrategie beim Low-grade Ovarialkarzinom. Eine deutschlandweite Umfrage der Charité – Berlin und Kliniken Essen Mitte mit Unterstützung der NOGGO und AGO

Geburtshilfe und Frauenheilkunde, 2018, Vol.78 (10)

2018

Volltextzugriff (PDF)

Erste Ergebnisse der Expression V Studie – Berliner Umfrage zu Erwartungen und Wünsche von Patientinnen mit und ohne Migrationshintergrund und gynäkologische Malignome

Geburtshilfe und Frauenheilkunde, 2016, Vol.76 (3)

2016

Volltextzugriff (PDF)

Expression III: Erwartungen und Präferenzen von Patientinnen mit Ovarialkarzinom. Eine Umfrage an 585 Patientinnen (NOGGO/Subanalyse der ENGOT ov4-Studie)

Geburtshilfe und Frauenheilkunde, 2016, Vol.76 (10)

2016

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(51)
Tagungsberichte
(9)

Sprache

Englisch
(41)
Deutsch
(19)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Oncology
(17)
Ovarian Cancer
(17)
Female
(16)
Humans
(16)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Middle Aged
(13)
Aged
(12)
Adult
(10)
Ovarian Neoplasms - Drug Therapy
(10)
Tumors
(9)
Biological And Medical Sciences
(8)
Chemotherapy
(8)
Medical Sciences
(8)
Ovarian Neoplasms - Pathology
(8)
Aged, 80 And Over
(7)
Gynecology. Andrology. Obstetrics
(6)
Doxorubicin - Analogs & Derivatives
(5)
Female Genital Diseases
(5)
Hematology, Oncology And Palliative Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany

A survey of treatment approaches of malignant ascites in Germany and Austria

Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome?

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients

Use of Paclitaxel for Advanced Ovarian Cancer in Clinical Practice: Analysis of 541 Patients. Results from a German Multi-centre Observational Study

Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial

Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries

MONITOR VII: Treatment strategies of low grade ovarian carcinomas – A German survey of the Charité – Berlin and Kliniken Essen Mitte with support of the study groups NOGGO and AGO

Expectations and perspectives of ovarian cancer patients about cancer management in Romania. The international NOGGO‐ENGOT trial: EXPRESSION III

Nachsorge des Ovarialkarzinoms

The Pathogenetic Mechanism of Anthracycline-induced Palmar-plantar Erythrodysesthesia

Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: results of a German multicenter observational study

Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: Results of a multicenter phase II study of the northeastern German society of gynecological oncology

8029 The expression of CASA in ascites correlates with the overall survival and clinical outcome in patients with ovarian cancer

000140 CAN A BIWEEKLY SCHEDULE REDUCE THE TOXICITY OF CAELYX? A PHASE-II STUDY OF HEAVILY PRETREATED PATIENTS WITH RECURRENT OVARIAN CANCER

Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

8002 What is the best schedule of Topotecan? – weekly versus routine 5-day schedule in patients with platinum-resistant ovarian cancer – a randomized, multicenter trial of the North-Eastern German Society of Gynaecological Oncology (TOWER)

8067 Platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

8057 How relevant is the CA-125 monitoring for patients with ovarian cancer in the follow-up? – Results from a multicenter survey in 1060 patients with ovarian cancer

00030 INFORMATION NEEDS AND PREFERENCES OF WOMEN WITH ADJUVANT AND METASTATIC BREAST CANCER (BC): RESULTS OF A SURVEY IN GERMANY

Aktuelle Aspekte der Therapie des platinresistenten Ovarialkarzinoms

995PMONITOR VII: Treatment strategies of low grade ovarian carcinomas - A German survey of the Charité - Berlin and Kliniken Essen Mitte with support of the study groups NOGGO and AGO

MONITOR VII – Behandlungsstrategie beim Low-grade Ovarialkarzinom. Eine deutschlandweite Umfrage der Charité – Berlin und Kliniken Essen Mitte mit Unterstützung der NOGGO und AGO

Erste Ergebnisse der Expression V Studie – Berliner Umfrage zu Erwartungen und Wünsche von Patientinnen mit und ohne Migrationshintergrund und gynäkologische Malignome

Expression III: Erwartungen und Präferenzen von Patientinnen mit Ovarialkarzinom. Eine Umfrage an 585 Patientinnen (NOGGO/Subanalyse der ENGOT ov4-Studie)

Suchergebnisse filtern